Excitation–inhibition imbalance links amyloid pathophysiology to cognition in non‐demented individuals #NeuroDegeneration 🧪🧠
https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.71891?af=R

Gene flux shapes diversity and evolution of the ancient 17q21.31 inversion polymorphism #NeuroDegeneration 🧪🧠
https://www.biorxiv.org/content/10.64898/2026.09.28.755014v1

Medial septum glutamatergic neurons support speed coding and grid cell spatial stability in the medial entorhinal cortex #NeuroDegeneration 🧪🧠
https://www.biorxiv.org/content/10.64898/2026.09.28.754654v1

Adaptive spatiotemporal filtering of social electrosensory signals by cerebellar feedback #NeuroDegeneration 🧪🧠
https://www.biorxiv.org/content/10.64898/2026.09.28.755101v1

PCK2 knockdown suppresses malignant phenotypes and is associated with ferroptosis-related changes in colorectal cancer cells #NeuroDegeneration 🧪🧠
https://www.researchsquare.com/article/rs-11075363/latest

Rapid Microanalysis-Based Process for Nuclear Material Characterization for Nuclear Forensics #NeuroDegeneration 🧪🧠
https://www.researchsquare.com/article/rs-11054810/latest

Thalamic volume links milder symptoms but faster dopaminergic decline in prodromal Parkinson disease #NeuroDegeneration 🧪🧠
https://www.researchsquare.com/article/rs-11083698/latest

Distinct lipid mediator profiles in brain and liver tissues in Alzheimer's disease #NeuroDegeneration 🧪🧠
https://www.medrxiv.org/content/10.64898/2026.09.22.26363708v1

Reactive and predictive processes during unpredictable driving hazards in virtual reality: an exploratory brain and body study with multimodal neurophysiological monitoring #NeuroDegeneration 🧪🧠
https://www.biorxiv.org/content/10.64898/2026.09.24.754154v1

Hierarchical control of remyelination by heparan sulfate sulfation #NeuroDegeneration 🧪🧠
https://www.biorxiv.org/content/10.64898/2026.09.24.754157v1

NeuronSifter: Intervention Planning in CNS Microenvironments #NeuroDegeneration 🧪🧠
https://arxiv.org/abs/2609.35445

GenomeOcean Anywhere: Private WebGPU Inference for Genome MoEs #NeuroDegeneration 🧪🧠
https://arxiv.org/abs/2609.35882

APOE ε4 Carrier Status and Cognitive Decline in Mild-to-Moderate Alzheimer's Disease: A Linear Mixed-Effects Analysis of the Placebo Arm of EXPEDITION 1 #NeuroDegeneration 🧪🧠
https://www.medrxiv.org/content/10.64898/2026.09.27.26364131v1

Alterations in relative perfusion and synaptic patterns in Parkinson's disease using dynamic SV2A PET #NeuroDegeneration 🧪🧠
https://www.medrxiv.org/content/10.64898/2026.09.28.26364237v1

Gantenerumab reduces brain amyloid-β proteoforms: Biochemical evaluation in dominantly inherited Alzheimer disease #NeuroDegeneration 🧪🧠
https://www.medrxiv.org/content/10.64898/2026.09.22.26363432v1

Striatal representations and network correlates of digital motor scores in Parkinsons disease #NeuroDegeneration 🧪🧠
https://www.medrxiv.org/content/10.64898/2026.09.27.26364116v1

Plasma immune signatures associate with neurodegeneration in frontotemporal lobar degeneration #NeuroDegeneration 🧪🧠
https://www.medrxiv.org/content/10.64898/2026.09.28.26364155v1

A neurocognitive speech taxonomy for voice biomarkers of Alzheimers disease #NeuroDegeneration 🧪🧠
https://www.medrxiv.org/content/10.64898/2026.09.23.26363671v1

Diagnostic accuracy of remote self-administered digital cognitive assessment by clinical diagnosis and Alzheimers disease PET imaging biomarkers #NeuroDegeneration 🧪🧠
https://www.medrxiv.org/content/10.64898/2026.09.20.26362296v1

Speech Timing Measures Are Not Interchangeable Across Elicitation Methods in Senior Living Residents #NeuroDegeneration 🧪🧠
https://www.medrxiv.org/content/10.64898/2026.09.23.26363840v1